Kusaba H, Kohno K, Asakuno K, Kuwano M, Okumura K, Green E D, Schlessinger D, Wada M
Department of Biochemistry, Kyushu University School of Medicine, Fukuoka, Japan.
Genome Res. 1995 Oct;5(3):245-58. doi: 10.1101/gr.5.3.245.
Multidrug resistance (MDR) genes, which are ATP-binding cassette family genes, encode the cell surface glycoprotein, P-glycoprotein, which functions as an energy-dependent drug efflux pump. Two relevant human genes, PGY1 and PGY3, are located on human chromosome 7, and three relevant mouse genes, mdr1a, mdr1b, and mdr2, are located on mouse chromosome 5. An LMD1 cell line was established after the transfer of a 580-kb yeast artificial chromosome (YAC) clone carrying the human MDR locus into mouse L cells; the cell line was shown to have stably integrated YAC DNA in an apparent intact form. Using LMD1 cells as the parental cell line, five vincristine-resistant sublines, designated LMD1-V50, LMD1-V100, LMD1-V200, LMD1-V500, and LMD1-V1000, were isolated by exposure to increasing concentrations of the drug. LMD1-V50, LMD1-V100, LMD1-V200, LMD1-V500, and LMD1-V1000 showed 3-, 7-, 13-, 45-, and 110-fold higher resistance to the cytotoxic effects of vincristine, respectively, than their parental counterpart, LMD1. Immunofluorescence, Western blot, and Northern blot analyses revealed that the human PGY1 gene or its product was overexpressed, accompanied by gene amplification. The human PGY3 gene was also overexpressed in the LMD1-V20, LMD1-V100, and LMD1-V1000 cell lines. Southern blot and fluorescence in situ hybridization (FISH) analyses demonstrated that although essentially the entire YAC DNA was integrated in mouse genome and amplified, the endogenous mouse mdr genes were not amplified in these drug-resistant cell lines. Similar results were obtained by the analyses of vincristine-resistant cell lines isolated from four independent subclones of LMD1 cells. Thus, in contrast to their mouse counterparts, the integrated human MDR genes retained susceptibility to both gene activation and amplification, during the selection of drug-resistant mouse cell lines. The possibility that transferred YACs may retain regulatory properties observed in the cells of origin, and may have a chromatin structure that favors augmented expression, is discussed.
多药耐药(MDR)基因属于ATP结合盒家族基因,编码细胞表面糖蛋白P - 糖蛋白,其作为一种能量依赖性药物外排泵发挥作用。两个相关的人类基因PGY1和PGY3位于人类7号染色体上,三个相关的小鼠基因mdr1a、mdr1b和mdr2位于小鼠5号染色体上。将携带人类MDR基因座的580kb酵母人工染色体(YAC)克隆转入小鼠L细胞后建立了LMD1细胞系;该细胞系被证明已将YAC DNA以明显完整的形式稳定整合。以LMD1细胞作为亲本细胞系,通过暴露于浓度递增的药物中,分离出五个长春新碱耐药亚系,分别命名为LMD1 - V50、LMD1 - V100、LMD1 - V200、LMD1 - V500和LMD1 - V1000。LMD1 - V50、LMD1 - V100、LMD1 - V200、LMD1 - V500和LMD1 - V1000对长春新碱细胞毒性作用的抗性分别比其亲本LMD1高3倍、7倍、13倍、45倍和110倍。免疫荧光、蛋白质印迹和Northern印迹分析显示,人类PGY1基因或其产物过度表达,并伴有基因扩增。人类PGY3基因在LMD1 - V20、LMD1 - V100和LMD1 - V1000细胞系中也过度表达。Southern印迹和荧光原位杂交(FISH)分析表明,虽然基本上整个YAC DNA已整合到小鼠基因组并扩增,但内源性小鼠mdr基因在这些耐药细胞系中未扩增。对从LMD1细胞的四个独立亚克隆中分离出的长春新碱耐药细胞系进行分析也得到了类似结果。因此,与小鼠对应基因不同,在选择耐药小鼠细胞系的过程中,整合的人类MDR基因对基因激活和扩增均保持敏感性。文中讨论了转移的YACs可能保留在起源细胞中观察到的调控特性,并且可能具有有利于增强表达的染色质结构的可能性。